Cargando…
High BMI is associated with lower TNF-α inhibitor serum trough levels and higher disease activity in patients with axial spondyloarthritis
BACKGROUND: TNF-α inhibitor (TNFi) serum trough levels have previously been found to be related to disease activity in axial spondyloarthritis (axSpA). However, most research regarding serum trough levels has been conducted in patients who only recently started TNFi therapy. Therefore, our objective...
Autores principales: | de Wolff, Liseth, Arends, Suzanne, Brouwer, Elisabeth, Bootsma, Hendrika, Spoorenberg, Anneke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10580642/ https://www.ncbi.nlm.nih.gov/pubmed/37848964 http://dx.doi.org/10.1186/s13075-023-03187-4 |
Ejemplares similares
-
CD27(-)CD38(low)CD21(low) B-Cells Are Increased in Axial Spondyloarthritis
por: Wilbrink, Rick, et al.
Publicado: (2021) -
Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis
por: Kieskamp, Stan C, et al.
Publicado: (2021) -
Ankylosing spondylitis patients at risk of poor radiographic outcome show diminishing spinal radiographic progression during long-term treatment with TNF-α inhibitors
por: Maas, Fiona, et al.
Publicado: (2017) -
Mucosal-associated invariant T cells in patients with axial spondyloarthritis
por: van der Meer, Rienk Gerben, et al.
Publicado: (2023) -
Psoriasis seems often underdiagnosed in patient with axial spondyloarthritis
por: Rondags, Angelique, et al.
Publicado: (2023)